These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 11483321

  • 1. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1123-35. PubMed ID: 11483321
    [Abstract] [Full Text] [Related]

  • 2. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.
    Ferrigno R, Campos de Oliveira Faria SL, Weltman E, Salvajoli JV, Segreto RA, Pastore A, Nadalin W.
    Int J Radiat Oncol Biol Phys; 2003 Mar 01; 55(3):695-706. PubMed ID: 12573757
    [Abstract] [Full Text] [Related]

  • 3. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC, Tung SY, Leung TW, Sze WK, Wong VY, Lui CM, Yuen KK, O SK.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1254-64. PubMed ID: 12654435
    [Abstract] [Full Text] [Related]

  • 4. Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy.
    Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko J, Pickel H, Hackl A.
    Radiother Oncol; 1997 Feb 01; 42(2):143-53. PubMed ID: 9106923
    [Abstract] [Full Text] [Related]

  • 5. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016
    [Abstract] [Full Text] [Related]

  • 6. High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system.
    Mosalaei A, Mohammadianpanah M, Omidvari S, Ahmadloo N.
    Int J Gynecol Cancer; 2006 Jul 15; 16(3):1101-5. PubMed ID: 16803492
    [Abstract] [Full Text] [Related]

  • 7. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW, Suh CO, Chung EJ, Kim GE.
    Int J Radiat Oncol Biol Phys; 2002 Apr 01; 52(5):1338-44. PubMed ID: 11955747
    [Abstract] [Full Text] [Related]

  • 8. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ, Huang EY, Sun LM, Chen HC, Fang FM, Hsu HC, Changchien CC, Leung SW.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):179-89. PubMed ID: 15093915
    [Abstract] [Full Text] [Related]

  • 9. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM, Gorla G, Gupta S, Garg M, Deore S, Runowicz CD, Fields AL, Goldberg GL, Anderson PS, Vikram B.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):702-6. PubMed ID: 12062615
    [Abstract] [Full Text] [Related]

  • 10. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC, Peng LC, Chen YH, Huang DY, Wu JK, Jian JJ.
    Int J Radiat Oncol Biol Phys; 2003 Nov 15; 57(4):1010-8. PubMed ID: 14575832
    [Abstract] [Full Text] [Related]

  • 11. High-dose-rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong: unexpectedly high complication rate.
    Choi P, Teo P, Foo W, O SK, Leung SF, Tsao SY, Shiu W.
    Clin Oncol (R Coll Radiol); 1992 May 15; 4(3):186-91. PubMed ID: 1586638
    [Abstract] [Full Text] [Related]

  • 12. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T, Kakinohana Y, Ogawa K, Adachi G, Moromizato H, Nagai Y, Maehama T, Sakumoto K, Kanazawa K, Murayama S.
    Int J Radiat Oncol Biol Phys; 2003 Aug 01; 56(5):1344-53. PubMed ID: 12873679
    [Abstract] [Full Text] [Related]

  • 13. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP.
    Brachytherapy; 2006 Aug 01; 5(4):218-22. PubMed ID: 17118313
    [Abstract] [Full Text] [Related]

  • 14. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN, Shrivastava SK, Jalali R, Agarwal JP, Deshpande DD, Nehru RM, Dinshaw KA.
    Strahlenther Onkol; 2001 Oct 01; 177(10):517-24. PubMed ID: 11680016
    [Abstract] [Full Text] [Related]

  • 15. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H.
    Cancer Radiother; 2000 Oct 01; 4(2):159-72. PubMed ID: 10812362
    [Abstract] [Full Text] [Related]

  • 16. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e49-56. PubMed ID: 21470794
    [Abstract] [Full Text] [Related]

  • 17. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?
    Kim HJ, Kim S, Ha SW, Wu HG.
    Tumori; 2008 Jan 01; 94(3):327-32. PubMed ID: 18705399
    [Abstract] [Full Text] [Related]

  • 18. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT, Jones B, Gee A, Kingston RE.
    Br J Radiol; 1997 Dec 01; 70(840):1259-69. PubMed ID: 9505845
    [Abstract] [Full Text] [Related]

  • 19. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD, Rai B, Mallick I, Sharma SC.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):125-30. PubMed ID: 15850912
    [Abstract] [Full Text] [Related]

  • 20. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N, Jamalludin Z, Ung NM, Ho GF, Malik RA, Phua VC.
    Asian Pac J Cancer Prev; 2014 May 01; 15(13):5259-64. PubMed ID: 25040985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.